Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP600677.RAcTzz3jwlYMaU5lJY9Raq0W-5JloqEx-hl6jgYDfBHto130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP600677.RAcTzz3jwlYMaU5lJY9Raq0W-5JloqEx-hl6jgYDfBHto130_assertion type Assertion NP600677.RAcTzz3jwlYMaU5lJY9Raq0W-5JloqEx-hl6jgYDfBHto130_head.
- NP600677.RAcTzz3jwlYMaU5lJY9Raq0W-5JloqEx-hl6jgYDfBHto130_assertion description "[We also demonstrated comprehensively that FLJ10540 and osteopontin were not only overexpressed in NPC specimens, but also significantly correlated with advanced tumor and lymph node-metastasis stages, and had a poor 5-year survival rate, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP600677.RAcTzz3jwlYMaU5lJY9Raq0W-5JloqEx-hl6jgYDfBHto130_provenance.
- NP600677.RAcTzz3jwlYMaU5lJY9Raq0W-5JloqEx-hl6jgYDfBHto130_assertion evidence source_evidence_literature NP600677.RAcTzz3jwlYMaU5lJY9Raq0W-5JloqEx-hl6jgYDfBHto130_provenance.
- NP600677.RAcTzz3jwlYMaU5lJY9Raq0W-5JloqEx-hl6jgYDfBHto130_assertion SIO_000772 22591637 NP600677.RAcTzz3jwlYMaU5lJY9Raq0W-5JloqEx-hl6jgYDfBHto130_provenance.
- NP600677.RAcTzz3jwlYMaU5lJY9Raq0W-5JloqEx-hl6jgYDfBHto130_assertion wasDerivedFrom befree-20140225 NP600677.RAcTzz3jwlYMaU5lJY9Raq0W-5JloqEx-hl6jgYDfBHto130_provenance.
- NP600677.RAcTzz3jwlYMaU5lJY9Raq0W-5JloqEx-hl6jgYDfBHto130_assertion wasGeneratedBy ECO_0000203 NP600677.RAcTzz3jwlYMaU5lJY9Raq0W-5JloqEx-hl6jgYDfBHto130_provenance.